Related Experiment Videos
Effects of CO2 rebreathing on pulmonary mechanics in premature infants
M J Miller1, J M DiFiore, K P Strohl
1Department of Pediatrics, Rainbow Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio 44106.
Insights
Inhaled carbon dioxide (CO2) reduces airway resistance in premature infants. This finding suggests improved airflow and respiratory response in neonates with hypercapnia.
Area of Science:
- Neonatal physiology
- Respiratory medicine
- Pediatric pulmonology
Background:
- Premature infants often experience respiratory challenges.
- Understanding airway resistance is crucial for neonatal respiratory support.
- Hypercapnia can impact respiratory drive and airflow.
Purpose of the Study:
- To investigate the effects of hypercapnia on total pulmonary, supraglottic, and lower airway resistance in premature infants.
- To determine if inhaled carbon dioxide (CO2) influences airway resistance in this population.
Main Methods:
- Eight premature infants underwent CO2 rebreathing trials during quiet sleep.
- Nasal airflow was measured using a mask pneumotachograph.
- Airway pressures were recorded using esophageal and oropharyngeal catheters.
Main Results:
- Total pulmonary resistance decreased significantly with increasing end-tidal PCO2 (PETCO2).
- Lower airway resistance (larynx and lungs) also showed a significant decrease as PETCO2 rose.
- Supraglottic airway resistance reduced during both inspiration and expiration with elevated PETCO2.
Conclusions:
- Inhaled CO2 leads to a decrease in airway resistance in premature infants.
- This reduction in resistance may enhance airflow and improve the infant's ventilatory response to CO2.
- Findings suggest a potential mechanism for improved respiratory function in neonates with hypercapnia.
Abstract:
The effects of hypercapnia produced by CO2 rebreathing on total pulmonary, supraglottic, and lower airway (larynx and lungs) resistance were determined in eight premature infants [gestational age at birth 32 +/- 3 (SE) wk, weight at study 1,950 +/- 150 g]. Nasal airflow was measured with a mask pneumotachograph, and pressures in the esophagus and oropharynx were measured with a fluid-filled or 5-Fr Millar pressure catheter. Trials of hyperoxic (40% inspired O2 fraction) CO2 rebreathing were performed during quiet sleep. Total pulmonary resistance decreased progressively as end-tidal PCO2 (PETCO2) increased from 63 +/- 23 to 23 +/- 15 cmH2O.l-1.s in inspiration and from 115 +/- 82 to 42 +/- 27 cmH2O.l-1.s in expiration between room air (PETCO2 37 Torr) and PETCO2 of 55 Torr (P less than 0.05). Lower airway resistance (larynx and lungs) also decreased from 52 +/- 22 to 18 +/- 14 cmH2O.l-1.s in inspiration and from 88 +/- 45 to 30 +/- 22 cmH2O.l-1.s in expiration between PETCO2 of 37 and 55 Torr, respectively (P less than 0.05). Resistance of the supraglottic airway also decreased during inspiration from 7.2 +/- 2.5 to 3.6 +/- 2.5 cmH2O.l-1.s and in expiration from 7.6 +/- 3.3 to 5.3 +/- 4.7 cmH2O.l-1.s at PETCO2 of 37 and 55 Torr (P less than 0.05). The decrease in resistance that occurs within the airway in response to inhaled CO2 may permit greater airflow at any level of respiratory drive, thereby improving the infant's response to CO2.